Related Experiment Video
Updated: May 30, 2026

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
Published on: April 21, 2012
A rare case of Visceral leishmaniasis with multiple relapse and multi-drug unresponsive: successfully treated with
Nawin Kumar1, Prabhat Kumar Sinha, Krishna Pandey
1Division of Clinical Medicine, RMRIMS (ICMR), Agamkuan, Patna, Bihar, 800 007, India. drnawinkumar@gmail.com
Case:
We report a 32-year old relapse case of Visceral leishmaniasis, treated with Paromomycin who belonged from a endemic zone of Bihar state, India. After confirmation, he was treated with Amphotericin B, followed by Liposomal Amphotericin B in full course and even in higher dose. But after each therapy, the patient either did not responded or relapsed after treatment. Ultimately, the patient was successfully treated with combination therapy of Liposomal amphotericin B and Miltefosine without any relapse.
Conclusion:
The multi-drug unresponsive Visceral leishmaniasis cases could pose a major threat to treatment strategy in the elimination program. In such situation, combination therapy seems to be a better approach that needs to be explored.
Related Concept Videos
Leishmaniasis
Antiprotozoal Agents
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Treatment Resistent Cancers
Retrovirus Life Cycles
Rocky Mountain Spotted Fever

